Company Filing History:
Years Active: 2018-2023
Title: The Innovations of David Nisim Giladi
Introduction
David Nisim Giladi is a notable inventor based in Netaniya, Israel. He has made significant contributions to the field of antibody therapies, holding a total of four patents. His work is primarily focused on the development of innovative approaches to cancer treatment.
Latest Patents
Among his latest patents are groundbreaking inventions related to anti-TIGIT antibodies and anti-PVRIG antibodies. These patents include combinations of anti-PVRIG and anti-TIGIT antibodies, showcasing his commitment to advancing therapeutic strategies in immuno-oncology.
Career Highlights
David currently serves as an essential member of Compugen Ltd., a corporation dedicated to discovering and developing therapeutic proteins for the treatment of cancer. His expertise in the field of biomedicine has allowed him to spearhead projects that may significantly impact patient outcomes.
Collaborations
Throughout his career, David has collaborated with talented professionals, including Mark Leslie White and Sandeep Kumar. These partnerships enhance the innovative capabilities of their research team, driving forward the quest for better cancer therapies.
Conclusion
David Nisim Giladi exemplifies the spirit of innovation and dedication in the healthcare industry. His continued work in antibody therapy positions him as a vital contributor to advancements that aim to transform treatment options for patients facing cancer. With his impressive patent portfolio, he stands at the forefront of medical innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.